Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
2.635
+0.005 (0.19%)
May 9, 2025, 11:28 AM - Market open
Cardiff Oncology Employees
As of December 31, 2024, Cardiff Oncology had 33 total employees, including 32 full-time and 1 part-time employees. The number of employees increased by 1 or 3.13% compared to the previous year.
Employees
33
Change (1Y)
1
Growth (1Y)
3.13%
Revenue / Employee
$17,788
Profits / Employee
-$1,481,152
Market Cap
175.29M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CRDF News
- 19 hours ago - Cardiff Oncology Reports First Quarter 2025 Results and Provides Business Update - GlobeNewsWire
- 7 days ago - Cardiff Oncology: Expecting Massive Updates In Colon Cancer Soon - Seeking Alpha
- 15 days ago - Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients - GlobeNewsWire
- 23 days ago - Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer - GlobeNewsWire
- 2 months ago - Cardiff Oncology, Inc. (CRDF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Cardiff Oncology to Present at Upcoming Investor Conferences - GlobeNewsWire